At the 2021 Clinical Trials on Alzheimer’s Disease Conference, Dr. Karlawish presented an ethical analysis in the panel discussion “The FDA accelerated approval of aducanumab.”

To watch, register via the link below and then find the recording on the CTAD 21 digital platform.